SARS-CoV-2免疫逃逸NTD中和抗体的分子机制
洪琴#,徐诗奇#,王艳兴,张超,黄忠*,丛尧*
(1.中国科学院分子细胞科学卓越创新中心(生物化学与细胞生物学研究所),上海200031; 2.中国科学院大学,北京100049;3.中国科学院上海免疫与感染研究所,上海200031)
摘 要 针对严重急性呼吸综合征冠状病毒2(Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)中和抗体的开发,主要针对SARS-CoV-2表面的刺突(Spike,S)蛋白。大多数中和SARS-CoV-2的单克隆抗体(MAbs)可结合S蛋白的受体结合结构域(receptor-binding domain,RBD),从而阻断病毒与血管紧张素转化酶2(Angiotensin-converting enzyme 2,ACE2)的相互作用。作者早期通过SARS-CoV-2原型株S蛋白免疫小鼠,筛选得到S2G4,S2H5,S4D4,S5B8 4株与S蛋白氮末端结构域(N-terminal domain,NTD)不同表位结合的单克隆抗体,其中S2H5活病毒中和能力最强。本研究利用冷冻电镜技术解析了S2H5的抗原结合片段(Fab)结合SARS-CoV-2原型株S蛋白复合体的结构,共获得六种构象,其中S2H5 Fab结合在S蛋白的NTD上,结构模拟完整S2H5抗体结合S蛋白可以空间上阻碍S蛋白与ACE2相互作用,揭示了S2H5中和SARS-CoV-2原型株的结构基础。此外,作者应用假病毒中和实验,分析了上述四种抗体对SARS-CoV-2多种突变株的中和能力,显示了其突变株对NTD抗体的免疫逃逸,并从结构生物学角度对各突变株表现出的免疫逃逸提供了可能的解释。
关键词 新型冠状病毒;刺突蛋白;中和抗体;冷冻电镜
中图分类号:Q7;Q51;Q336 文献标识码:A doi:10.3969/j.issn.1000-6281.2024.03.009
Molecular basis of SARS-CoV-2 immune evasion to NTD neutralizing antibodies
HONG Qin1,2#,XU Shiqi2,3#,WANG Yanxing1,ZHANG Chao3,HUANG Zhong3*,CONG Yao1*
(1. Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science,Chinese Academy of Sciences, Shanghai 200031;2. University of Chinese Academy of Sciences, Beijing 100049;3. Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai 200031, China)
Abstract Neutralizing antibodies play an important role in the immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The spike (S) protein on the surface of SARS-CoV-2 is the main target for neutralizing antibody development. Most monoclonal antibodies (MAbs) capable of neutralizing SARS-CoV-2 bind to the receptor-binding domain (RBD) of the S protein and thus are able to block binding of the virus to its host receptor, angiotensin-converting enzyme 2(ACE2). We earlyimmunized mice with the S protein of the SARS-CoV-2 wildtype strain and identified four neutralizing MAbs, namely S2G4,S2H5,S4D4and S5B8, targeting different epitopes of N-terminal domain (NTD),among which S2H5has the strongest neutralization ability against live WT SARS-COV-2.In this study, cryo-EM was used to analyze the structure of SARS-CoV-2 S trimer in complex with the Fab of S2H5, and obtain six cryo-EM maps, in which the S2H5 Fab was bound to the NTD of the S protein, and the structure was simulated binding of the intact S2H5 antibody to the S protein can sterically hinder the interaction of the S protein with ACE2,revealing the structural basis for S2H5 neutralization of the wildtype SARS-CoV-2. Moreover, by performing pseudovirus neutralization assays, we show that major SARS-CoV-2 variants significantly evade neutralization by the four NTD antibodies, in particular S2H5. Our work thus reveals the extensive immune evasion from NTD antibodies by SARS-CoV-2 variants and also provides a structural explanation for this phenomenon.
Keywords SARS-CoV-2; spike protein; neutralizing antibodies; Cryo-EM
“全文下载请到同方知网,万方数据库或重庆维普等数据库中下载!”
[1] TANG T, BIDON M, JAIMES J A, et al. Coronavirus membrane fusion mechanism offers a potential target for antiviral development[[J]. Antiviral Res, 2020, 178: 104792.
[2] WrappD, WangN, CORBETT K S, et al. Cryo-EM structure of the 2019-nCoV spike in theprefusion conformation[J]. Science, 2020, 367(6438): 1260-1263.
[3] Xu C,WANG Y X, LIU C X, et al. Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by Cryo-EM[J]. SCIENCE ADVANCES, 2021, 7(1): eabe5575.
[4] Krempl C, Schultze B, Laude H, et al. Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus[J]. J Virol, 1997, 71(4): 3285-3287.
[5] Lu G W, Wang Q H, GaoGF. Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond[J]. Trends Microbiol, 2015, 23(8): 468-478.
[6] Zhou H X, CHEN Y Z, ZHANG S Y, et al. Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein[J]. Nat Commun, 2019, 10(1): 3068.
[7] Hansen J, BaumA, PASCAL K E, et al. Studies in humanized mice and convalescent humansyield a SARS-CoV-2 antibody cocktail[J]. Science, 2020, 369(6506): 1010-1014.
[8] Noy-Porat T, MECHALY A, LEVY Y, et al. Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice[J]. iScience, 2021, 24(5): 102479.
[9] Zhang C, Wang Y F, ZHU Y F, et al. Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections[J]. Nature Communications, 2021, 12(1): 264.
[10] Wang N, SUN Y, FENG R, et al. Structure-based development of human antibody cocktails against SARS-CoV-2[J]. Cell Res, 2021, 31(1): 101-103.
[11] Chi X Y, YAN R H, ZHANG J, et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2[J]. Science, 2020, 369(6504): 650-655.
[12] XuS Q, WANG Y F, WANG Y X, et al. Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein[J]. Emerging Microbes & Infections, 2022, 11(1): 351-367.
[13] Fernandez-Leiro R, Scheres S H W. A pipeline approach to single-particle processing in RELION[J]. Acta Crystallogr D Struct Biol, 2017, 73(Pt 6): 496-502.
[14] Zheng S Q, PALOVCAK E, ARMACHE J P, et al. MotionCor2: Anisotropic correction of beam-induced motion for improved cryo-electron microscopy[J]. Nat Methods, 2017, 14(4): 331-332.
[15] Rohou A, Grigorief f N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs[J]. J Struct Biol, 2015, 192(2): 216-221.
[16] Biasini M, BIENERT S, WATERHOUSE A, et al. SWISS-MODEL: Modelling protein tertiary and quaternary structure using evolutionary information[J]. Nucleic Acids Research, 2014, 42(Web Serverissue): W252-W258.
[17] Pettersen E F, GODDARD T D, HUANG C C, et al. UCSF chimera - A visualization system for exploratory research and analysis[J]. Journal of Computational Chemistry, 2004, 25(13): 1605-1612.
[18] DiMaio F, SONG Y F, LI X M, et al. Atomic-accuracy models from 4.5-A Cryo-electron microscopy data with density-guided iterative local refinement[J]. Nat Methods, 2015, 12(4): 361-365.
[19] Adams P D, AFONINE P V, BunkócziG, et al. PHENIX: A comprehensive Python-based system for macromolecular structure solution[J]. Acta Crystallogr D Biol Crystallogr, 2010, 66(Pt 2): 213-221.
[20] Goddard T D, HUANG C C, MENG E C, et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis[J]. Protein Science, 2018, 27(1): 14-25.
[21] 张佳星,陈勇,李赛. 冷冻电镜断层成像技术破解重构新冠病毒全分子结构难题[J].电子显微学报, 2020, 39(6):787-789.
[22] ChiX Y, YAN R H, ZHANG J, et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2[J]. Science, 2020, 369(6504):650-655.
[23] McCallum M, De MARCO a, lempp F A, et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2[J]. Cell, 2021, 184(9): 2332-2347.
[24] Chen R E, ZHANG X, CASE J B, et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies[J]. Nature Medicine, 2021, 27(4): 717-726.
[25] Wang P, NAIR M S, LIU L, et al. Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7[J]. Nature, 2021, 593(7857): 130-135.
[26] Wang N S, ROSEN O, WANG L S,et al. Structural definition of a neutralization-sensitive epitope on the MERS-CoV S1-NTD[J]. Cell Reports, 2019, 28(13): 3395-3405.
[27] Cerutti G,GUO Y C, ZHOU T Q, et al. Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite[J]. Cell Host Microbe, 2021, 29(5): 819-833.
[28] Hong Q, HAN W Y, LI J W, et al. Molecular basis of receptor binding and antibody neutralization of Omicron[J]. Nature, 2022,604(7906): 546-552.